The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The importance of genomic testing and analysis in Waldenström’s macroglobulinemia
Amy Christian, BSc, MSc, University Hospitals Dorset NHS Foundation Trust, Dorset, UK, briefly discusses the importance of genomic testing and analysis in patients with Waldenström’s macroglobulinemia (WM), highlighting the value of optimizing approaches to genomic testing, and future outlooks. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
